Navigation Links
Developing High-Value Competitive Intelligence Functions in the Pharmaceutical Industry
Date:11/8/2013

CHAPEL HILL, N.C., Nov. 8, 2013 /PRNewswire/ -- The competitive intelligence (CI) function within pharmaceutical and related industries plays an incremental role in transforming competitive data into actionable insights that have a financial impact for the company. Despite this, the CI function is still not seen as a traditional corporate function, such as Finance or Sales. Because of this, the value of the function remains poorly understood by senior leadership.

Recent research by benchmarking firm Best Practices, LLC offers critical insights for healthcare leaders on how to increase the value of their CI function. Value of the CI function is often judged by a leader's ability to 'move the needle' by producing some kind of measurable financial outcome for their company. In order to justify the function to leaders, savvy groups must measure their CI impact in financial terms that executives can understand and believe.  

The report, "How Successful Companies Create and Develop a High-Value CI Function to Drive Better Business Decisions," identifies best practices and innovative methods for improving the strategic role and impact of the CI function within the pharmaceutical and related industries. The study also identifies current trends in structuring and activities completed by the function that will allow leaders to evaluate their organization's CI function relative to other leading companies.

Key study topics covered include:

  • Sources & Activities
  • Budget & FTE Levels
  • Uses of Third Party Vendors
  • Top 5 CI Employee Skills
  • CI Evolution & Trends
  • Structure & Leadership
  • Best Practices & Lessons Learned

This benchmarking research drew participation from 35 Competitive Intelligence leaders from 32 companies in the healthcare industry. Participants represented small, midcap and large biopharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with six selected respondents to gather additional insights.

To learn more about this report, download a complimentary excerpt at http://www.best-in-class.com/rr1247.htm.

For more information on other recent primary research studies, contact us at 919.403.0251 or visit our website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Pharmaceutical Product Launch Spend: Developing Competitive Launch and Pre-launch Budgets to Ensure a Successful Market Entry
2. Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
3. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
4. XBiotech Announces it is Developing Therapy for MRSA
5. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
6. Global Good and AUCMA Partner to Commercialize Vaccine Storage Invention for Developing Countries
7. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
8. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
9. Foundation Venture Capital Group Invests In Company Developing Implantable Meniscus for Knee Repair
10. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
11. Report Finds Big Pharma is Doing More for Access to Medicine in Developing Countries than Two Years Ago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Summary ... disease pipeline guide Primary Hyperoxaluria - Pipeline Review, ... Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline ... characterized by recurrent kidney and bladder stones. It ... oxalate. Symptoms include blood in the urine, pain ...
(Date:3/23/2017)... and VANCOUVER, British Columbia ... SPHS ) (the "Company" or "Sophiris"), a ... treatment of urological diseases, today announced that data from ... the drug as a focal treatment for localized prostate ... 26, 2017 at the 32 nd Annual European ...
(Date:3/23/2017)...   Icertis , the leading provider of ... today announced an upgrade to the Icertis Clinical ... clinical trials contract management. Built on the ... speeds up clinical trial contracting while improving collaboration ... "The pharmaceutical industry is under intense ...
Breaking Medicine Technology:
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for Garden Media ... All through the year, Garden Media aims to provide material helpful to clients’ goals ... pitching client’s key messages to gain coveted media placements, Garden Media wows ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet ... a conversation on the current obstacles facing infection prevention and offer strategies for ... caused by these infections. , The print component of “Fighting Infection” is ...
(Date:3/24/2017)... ... ... According to a new study by NCPA Senior Fellow John R. Graham, ... Congress has directed the CBO to follow. The CBO itself previously recognized Obamacare would ... estimates a reduction in employer-based coverage due to the GOP reform, which is not ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer and teacher ... Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat with world ... and spiritual journey during the Summer Solstice will also be her final international ...
(Date:3/24/2017)... CA (PRWEB) , ... March 24, 2017 , ... ... on two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, ... Creating the Administrative Record, The majority of cases litigated under ERISA involve claims ...
Breaking Medicine News(10 mins):